PageGroup & Oxford Nanopore: Markets live
PageGroup shares rose over 11% after it reported Q2 gross profit of £198m, down 0.2% year on year but ahead of analyst expectations, and said it sees signs of market normalisation. ME Group International gained about 11% after interim results showed flat £154m sales. Plus500 shares fell on weaker cash margin, and Oxford Nanopore dropped 12% after H1 sales missed expectations at £116.5m.
How this was made
The 30-second read
Why it matters
The article provides concrete Q2/Q1 datapoints and management commentary that explain immediate price moves: PAGE on a gross profit beat and normalization signs, MEGP on interim stabilization after a profit warning, PLUS on strong customer income but margin/cash profit weakness, and ONT on below-expectations sales and conditional path to full-year guidance.
Market read
Traders can use the disclosed beats/misses, margin dynamics, and conditional guidance language to frame near-term positioning into upcoming full-year result dates.
What to watch
For MEGP, the June FY guidance cut remains the key overhang despite interim stabilization; for PLUS, the revenue and customer growth strength may not translate into cash profit if acquisition costs stay elevated, keeping valuation sensitive to margin trajectory.
Background
This is a markets-live style roundup focused on same-day reactions to trading updates across PageGroup, ME Group International, Plus500, and Oxford Nanopore.
Ticker impact
Plus500 is discussed as delivering a first-half trading update with highest customer income in five years, but shares pulled back as cash profit growth lagged revenue.
Expect choppy trading as investors weigh revenue momentum against margin compression and forward-prospect tone.
The article provides concrete H1 metrics and explains the pullback via EBITDA margin decline and higher acquisition costs, which typically drives near-term valuation debate.
Oxford Nanopore fell about 12% after saying first-half sales were below expectations and it needs additional collaboration and licensing to meet full-year growth guidance.
Downside pressure likely persists until 19 August full results clarify China/Middle East weakness and the credibility/timing of licensing collaborations.
The article directly links the drop to below-expectations sales and explicitly conditions meeting guidance on additional collaboration and licensing revenue.
Market effects
Recruitment and life-science tools names show divergent demand signals, while CFD broker updates highlight sensitivity to acquisition costs and margin discipline.
PAGE cites growth in Americas and Asia Pacific but weakness in EMEA, while ONT flags China export restrictions and Middle East war-related demand pressure.
The piece reflects ongoing cross-region uncertainty and regulatory/export constraints affecting growth trajectories across sectors.
Counterpoint
PAGE’s “normalisation” language comes with unchanged operating profit guidance, suggesting the rally may be front-running without a fundamental upgrade; ONT’s licensing plan could still be achievable if collaborations materialize quickly.
Key entities
- public_companyPageGroup
Recruiter reporting Q2 gross profit beat and “signs of normalisation,” with unchanged 2026 operating profit guidance.
- public_companyME Group International
Photobooth and passport photo operator reporting interim results with improved trading after a prior profit warning.
- public_companyPlus500
Online CFD trading platform reporting H1 customer income growth but cash profit and EBITDA margin decline.
- public_companyOxford Nanopore
Gene-testing specialist reporting H1 sales below expectations and needing additional collaboration/licensing to meet full-year growth guidance.
